RIZATRIPTAN ODT GH rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt gh rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack

generic health pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: mannitol; microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; crospovidone; aspartame; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-au rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: calcium silicate; magnesium stearate; aspartame; mannitol; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ODT GH rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan odt gh rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack

generic health pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; mannitol; microcrystalline cellulose; magnesium stearate; calcium silicate; flavour - rizatriptan odt gh is indicated for the acute treatment of migraine attacks with or without aura.

MAXATAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters Australia - English - Department of Health (Therapeutic Goods Administration)

maxatan rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: acesulfame potassium; mannitol; sodium stearylfumarate; hypromellose; colloidal anhydrous silica; ethylcellulose; crospovidone; silicon dioxide; flavour - for acute treatment of migraine attacks with or without aura.

APO-RIZATRIPTAN rizatriptan (as benzoate) 5 mg orally disintegrating tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-rizatriptan rizatriptan (as benzoate) 5 mg orally disintegrating tablets blister pack

arrotex pharmaceuticals pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: sucralose; magnesium stearate; mannitol; crospovidone; microcrystalline cellulose; flavour - rizatriptan is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN-AU rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-au rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

medsurge pharma pty ltd - rizatriptan benzoate, quantity: 14.53 mg (equivalent: rizatriptan, qty 10 mg) - tablet, orally disintegrating - excipient ingredients: crospovidone; aspartame; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; calcium silicate; mannitol; flavour - rizatriptan-au is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ACT rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan act rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

medis pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: calcium silicate; aspartame; magnesium stearate; mannitol; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; flavour - rizatriptan act is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN-MEDIS rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan-medis rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

medis pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: magnesium stearate; calcium silicate; aspartame; colloidal anhydrous silica; microcrystalline cellulose; mannitol; crospovidone; flavour - rizatriptan-medis is indicated for the acute treatment of migraine attacks with or without aura.

RIZATRIPTAN ACTAVIS rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

rizatriptan actavis rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

medis pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - tablet, orally disintegrating - excipient ingredients: calcium silicate; magnesium stearate; mannitol; aspartame; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; flavour - rizatriptan actavis is indicated for the acute treatment of migraine attacks with or without aura.

MAXALT rizatriptan (as benzoate) 5mg wafer blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

maxalt rizatriptan (as benzoate) 5mg wafer blister pack

organon pharma pty ltd - rizatriptan benzoate, quantity: 7.265 mg (equivalent: rizatriptan, qty 5 mg) - wafer - excipient ingredients: glycine; gelatin; mannitol; aspartame; flavour - maxalt is indicated for the acute treatment of migraine attacks with or without aura.